139
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Amphotericin B microspheres: A therapeutic approach to minimize toxicity while maintaining antifungal efficacy

, , &
Pages 580-587 | Received 01 Feb 2009, Accepted 04 Feb 2009, Published online: 05 Nov 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sima Singh, Afzal Hussain, Faiyaz Shakeel, Mohamed Jawed Ahsan, Sultan Alshehri, Thomas J Webster & Uma Ranjan Lal. (2019) Recent insights on nanomedicine for augmented infection control. International Journal of Nanomedicine 14, pages 2301-2325.
Read now

Articles from other publishers (11)

Zhongyi MA, Xinyu WANG & Chong LI. (2023) Advances in anti-invasive fungal drug delivery systems. Journal of Zhejiang University (Medical Sciences) 52:3, pages 318-327.
Crossref
Changsomba Chang & Pratima Gupta. (2022) In-situ degradation of Amphotericin B in a microbial electrochemical cell containing wastewater. Chemosphere 309, pages 136726.
Crossref
Utkarsh Chadha, Senthil Kumaran Selvaraj, Hridya Ashokan, Sai P. Hariharan, V. Mathew Paul, Vishal Venkatarangan & Velmurugan Paramasivam. (2022) Complex Nanomaterials in Catalysis for Chemically Significant Applications: From Synthesis and Hydrocarbon Processing to Renewable Energy Applications. Advances in Materials Science and Engineering 2022, pages 1-72.
Crossref
Phyo Darli Maw & Phatsawee Jansook. (2022) Cyclodextrin-based Pickering nanoemulsions containing amphotericin B: Part I. evaluation of oil/cyclodextrin and amphotericin B/cyclodextrin inclusion complexes. Journal of Drug Delivery Science and Technology 68, pages 103118.
Crossref
Benedikt Göttel, Henrike Lucas, Frank Syrowatka, Wolfgang Knolle, Judith Kuntsche, Joana Heinzelmann, Arne Viestenz & Karsten Mäder. (2020) In situ Gelling Amphotericin B Nanofibers: A New Option for the Treatment of Keratomycosis. Frontiers in Bioengineering and Biotechnology 8.
Crossref
R. Silva-Carvalho, J. Fidalgo, K.R. Melo, M.F. Queiroz, S. Leal, H.A. Rocha, T. Cruz, P. Parpot, A.M. Tomás & M. Gama. (2020) Development of dextrin-amphotericin B formulations for the treatment of Leishmaniasis. International Journal of Biological Macromolecules 153, pages 276-288.
Crossref
Fang Liu, Liu Yang, Yamin Li, Ashlee Junier, Feihe Ma, Jinjin Chen, Haobo Han, Zachary Glass, Xuewei Zhao, Carol A. Kumamoto, Hong Sang & Qiaobing Xu. (2020) In Vitro and In Vivo Study of Amphotericin B Formulation with Quaternized Bioreducible Lipidoids . ACS Biomaterials Science & Engineering 6:2, pages 1064-1073.
Crossref
Raquel Fernández-García, Esther de Pablo, María Paloma Ballesteros & Dolores R. Serrano. (2017) Unmet clinical needs in the treatment of systemic fungal infections: The role of amphotericin B and drug targeting. International Journal of Pharmaceutics 525:1, pages 139-148.
Crossref
Helga K. Ruiz, Dolores R. Serrano, María Auxiliadora Dea-Ayuela, Pablo E. Bilbao-Ramos, Francisco Bolás-Fernández, Juan J. Torrado & Gloria Molero. (2014) New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp. International Journal of Pharmaceutics 473:1-2, pages 148-157.
Crossref
Ye-Tae Kim, Baek-Ki Shin, Vivek Kumar Garripelli, Jin-Ki Kim, Enkhzaya Davaa, Seongbong Jo & Jeong-Sook Park. (2010) A thermosensitive vaginal gel formulation with HPγCD for the pH-dependent release and solubilization of amphotericin B. European Journal of Pharmaceutical Sciences 41:2, pages 399-406.
Crossref
Qamar Zia, Mohammad Farzuddin, Mairaj Ahmad Ansari, Maroof Alam, Azmat Ali, Iqbal Ahmad & Mohammad Owais. 2010. Combating Fungal Infections. Combating Fungal Infections 485 528 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.